Form 4 Filing for GENELUX Corp

This filing details a Form 4 filed by Yu Yong, Chief Scientific Officer of GENELUX Corp, on June 18, 2026. The transaction, which occurred on June 16, 2026, involved the acquisition of 119,318 shares of Common Stock under the Issuer's 2022 Equity Incentive Plan. These shares were granted as restricted stock units (RSUs) with a transaction price of $0.00. Following this acquisition, Yu Yong now holds 269,024 shares. The RSUs are subject to a vesting schedule, with 25% vesting on the first anniversary of the grant date and the remaining shares vesting in 12 equal quarterly installments thereafter. This transaction is classified as an equity grant under the company's incentive plan.